Covered recipient · General Payments record
ALAINE E GADA
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2021–2024
$368.11
- Reported across 13 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $160.96 | 7 |
| Education | $3.08 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Relypsa, Inc. | $74.02 | 3 |
| Otsuka America Pharmaceutical, Inc. | $26.64 | 1 |
| Ardelyx, Inc. | $24.43 | 1 |
| Retrophin, Inc. | $20.63 | 2 |
| Amgen Inc. | $18.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.32 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117256079 | CMS |
| Ardelyx, Inc. | $24.43 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146681143 | CMS |
| Otsuka America Pharmaceutical, Inc. | $26.64 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118894964 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 04/10/2024 | Education | Undisputed | 01/23/2026 | 1149887845 | CMS |
| Travere Therapeutics, Inc. | $17.55 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149887849 | CMS |
| Vifor Pharma, Inc. | $24.67 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124044761 | CMS |
| Vifor Pharma, Inc. | $30.09 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124045743 | CMS |
| Vifor Pharma, Inc. | $19.26 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124036360 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.